Agilent Technologies and the National University of Singapore (NUS) announced a collaboration in analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states.
Agilent’s provision of sophisticated test and measurement instruments will be housed in the NUS Center for Lipidomics within the university’s Life Sciences Institute. Headed by associate professor Markus Wenk, NUS department of biochemistry and department of biological sciences, this center will host researchers and scientists from clinical and commercial organizations in Singapore and the Asia Pacific region.
“Lipids play crucial roles in pathophysiology,” said professor John Wong, dean of the NUS Yong Loo Lin School of Medicine. “The close proximity of this new center to clinical research and patient care at the National University health system places us in a unique position for knowledge creation and translation in biomedicine.”